Pharvaris PHVS
NASDAQ PHVS
$35.55 -0.11 (-0.31%)
As of: Sep 4, 2026 · 3:11 PM EDT

Pharvaris (PHVS) Receivables - Other (2025)

Analysis

Pharvaris (PHVS) Receivables - Other (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.58 Bn 130.73 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.33 Bn 77.33 Bn 3.93 Bn
3 Argenx Se 63.43 Bn 58.24 Bn 1.37 Bn
4 Moderna 57.84 Bn 52.70 Bn 52.00 Mn
5 Revolution Medicines 44.01 Bn 44.01 Bn -
6 BeOne Medicines 39.93 Bn 34.83 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.47 Bn 32.16 Bn 992.69 Mn
8 Royalty Pharma 28.39 Bn 27.56 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Pharvaris 2.11 Bn 1.74 Bn 85,072.10
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 7.41 Mn